Verition Fund Management LLC - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607AB6. A total of 26 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Verition Fund Management LLC ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$30,786,560
+42.0%
16,459,000
-36.6%
0.48%
+96.3%
Q3 2022$21,680,659
-34.7%
25,954,000
+2.7%
0.24%
-38.6%
Q1 2022$33,205,000
-8.3%
25,275,000
+2.4%
0.40%
+52.9%
Q4 2021$36,219,000
-9.6%
24,689,000
-8.7%
0.26%
-24.8%
Q3 2021$40,063,000
+12.2%
27,047,0000.0%0.35%
+6.8%
Q2 2021$35,719,000
+5.4%
27,047,000
+4.5%
0.32%
-14.9%
Q1 2021$33,874,000
-4.6%
25,883,000
+79.0%
0.38%
+22.8%
Q4 2020$35,496,000
+14.4%
14,463,000
-3.2%
0.31%
-49.8%
Q3 2020$31,032,000
-9.6%
14,948,0000.0%0.62%
-45.1%
Q2 2020$34,343,000
+53.3%
14,948,000
+1.4%
1.13%
+27.7%
Q1 2020$22,403,000
-13.8%
14,735,000
+10.4%
0.88%
+86.9%
Q4 2019$25,982,000
+301.4%
13,341,000
+172.8%
0.47%
+165.7%
Q3 2019$6,473,000
-31.3%
4,890,000
+15.7%
0.18%
-32.8%
Q2 2019$9,422,000
-25.0%
4,228,000
-39.0%
0.26%
-45.8%
Q1 2019$12,557,0006,935,0000.49%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
DeepCurrents Investment Group LLC 53,865,000$101,127,2803.93%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 88,657,000$165,397,6133.42%
Boussard & Gavaudan Investment Management LLP 11,898$21,871,5382.42%
TENOR CAPITAL MANAGEMENT Co., L.P. 38,394,000$71,834,2261.71%
WOLVERINE ASSET MANAGEMENT LLC 79,876,000$149,367,3841.55%
CSS LLC/IL 4,747,000$8,868,6060.50%
Opti Capital Management, LP 3,000,000$5,611,9380.48%
Verition Fund Management LLC 16,459,000$30,786,5600.48%
Aequim Alternative Investments LP 5,000,000$9,352,5000.25%
MIZUHO SECURITIES USA LLC 1,097,000$2,047,6160.19%
View complete list of SAREPTA THERAPEUTICS INC shareholders